References
- S.GaikwadA.IngleA.GadeM.RaiA.FalangaN.IncoronatoAntiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3Int J Nanomed8201343034314
- N.KhandelwalG.KaurN.KumaraA.TiwariApplication of silver nanoparticles in viral inhibition: a new hope for antiviralsDigest J Nanomat Biostruct92014175186
- S.GaldieroA.FalangaM.VitielloM.CantisaniV.MarraM.GaldieroSilver Nanoparticles as Potential Antiviral AgentsRev Molec16201188948918
- M.RaiA.YadavA.GadeSilver nanoparticles as a new generation of antimicrobialsBiotechnol Adv2720097683
- M.SmekalovaV.AragonA.PanacekR.PrucekR.ZborilL.KvitekEnhanced antibacterial effect of antibiotics in combination with silver nanoparticles against animal pathogensThe Vet J2092016174179 10.1016/j.tvjl.2015.10.032
- J.V.RogersC.V.ParkinsonY.W.ChoiJ.L.SpeshockA preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formationNanoscale Res Lett32008129133
- D.Baram-PintoS.ShuklaA.GedankenR.SaridInhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticlesSmall6201010441050
- H.H.LaraN.V.Ayala-NuñezL.Ixtepan-TurrentC.Rodriguez-PadillaMode of antiviral action of silver nanoparticles against HIV-1J Nanobiotech82010110
- T.Q.HuyT.N.ThanhN.T.ThuyP.V.ChungP.N.HungA.T.LeCytotoxicity and antiviral activity of electrochemical – Synthesized silver nanoparticles against poliovirusJ Virol Meth24120175257 10.1016/j.jviromet.2016.12.015
- B.BorregoL.O.GemaD.M.JosuéH.Almanza-ReyesF.MateosL.López-GilPotential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivoNanomedicine: NBM12201611851192 10.1016/j.nano.2016.01.021
- Y.MuktarT.BikilaM.KeffaleApplication of nanotechnology for animal health and production improvementWASJ33201515881596
- N.S.MeenaY.P.SahniD.ThakurR.P.SinghApplications of nanotechnology in veterinary therapeuticsJ Entomol Zool Stud62018167175
- R.DosokyS.KotbM.M.FarghaliEfficiency of silver nanoparticles against bacterial contaminants isolated from surface and ground water in EgyptJ Adv Vet Anim Res22015175184
- U.T.IscanR.DumanBovine herpesvirus type- 1 (BHV-1) prevalence in dairy cattleJAVA10201115231525
- S.S.PawarC.D.MeshramN.K.SinghM.SainiB.P.MishraP.K.GuptaDevelopment of a SYBR Green I based duplex real-time PCR for detection of bovine herpesvirus-1 in semenJ Virol Methods2082014610
- S.T.OmaraM.F.ZawrahA.A.SamMinimum bactericidal concentration of chemically synthesized silver nanoparticles against pathogenic Salmonella and Shigella strains isolated from layer poultry farmsJ App Pharma Sci72017214221
- L.J.ReedH.MuenchA simple method for estimating fifty percent endpointsAm J Hyg271938493497
- M.B.HansenS.E.NielsenK.BergRe-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJ Immune Meth1191989203210
- A.A.Al-JabriM.D.WiggOxford J.S. Initial in vitro screening of drug candidates for determinants potential antiviral activities, In: Mahy, B.W.J. site rRNA model oligonucleotide. Journal of and H.O. Kangro (Eds.),Virol meth manualMolec Biol2621996421436
- Repetto G, Peso AD, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. National Institute of Toxic and Foren Sci Nature Protocols 2008;3:pp. 1125–1131.
- A.HaiderI.KangPreparation of silver nanoparticles and their industrial and biomedical applications: a comprehensive reviewAdvan Mater Sci Eng162015 165257
- I.KhanK.SaeedI.KhanNanoparticles: Properties, applications and toxicities.Arabian J Chem2017 10.1016/j.arabjc.2017.05.011
- L.CastroM.L.BlázquezJ.A.MuñozA.BallesterMechanism and applications of metal nanoparticles prepared by bio-mediated processRev Adv Sci and Eng32014118
- S.E.AshbaughK.E.ThompsonE.B.BelknapP.C.SchultheissS.I.ChowdhuryJ.K.CollinsSpecific detection of shedding and latency of bovine herpesvirus 1 and 5 using a nested polymerase chain reactionJ Vet Diagn Invest91997387394
- ICVT. Virus Taxonomy 2015; Release EC 47, London, UK, ICTV. “Virus Taxonomy: 201 Release”4. Retrieved 15 June 2015.
- M.EngelsC.GiulianiP.WildT.M.BeckE.LoepfeR.WylerThe genome of bovine herpesvirus 1 (BHV-1) strains exhibiting a neuropathogenic potential compared to known BHV-1 strains by restriction site mapping and cross-hybridizationVirus Res619865773
- S.K.TikooM.CamposL.A.BabiukBovine herpesvirus 1 (BHV-1): biology, pathogenesis and controlAdv Virus Res451995191223
- M.SchwyzerM.AckermannMolecular virology of ruminant herpesvirusesVet Microbiol5319961729
- S.RoelsG.CharlierC.LetellierG.MeyerF.SchyntsP.KerkhofsNatural case of bovine herpesvirus 1 meningoencephalitis in an adult cowVet Rec1462000586588
- M.T.WinklerA.DosterC.JonesPersistence and reactivation of bovine herpesvirus 1 in the tonsils of latently infected calvesJ Virol74200053375346
- C.JonesHerpes simplex virus type 1and bovine herpesvirus 1 latencyClin Microbiol Rev1620037995
- C.AbrilM.EngelsA.LimmanM.HilbeS.AlbiniM.FranchiniBoth viral and host factors contribute to neurovirulence of bovine herpesvirus 1 and 5 in ineter feron receptor-deficient miceJ Virol78200436443653
- L.R.DevireddyC.V.JonesActivation of caspase and P53 by bovine herpesvirus 1 infection result in programmed cell death and efficient virus releaseJ Virol7199937783788
- V.MisraS.WalkerS.HayesP.Oharethe bovine herps virus alpha gene trans-inducing factor activates transcription by mechanisms different from those of its herps simplex virus type 1counterpartJ Virol69199552095216
- L.LovatoM.InmanG.HendersonA.DosterC.JonesInfection of cattle with a BHV-1 strain that contains a mutation in the latency related gene leads to increase a apoptosis in TG during the transition from acute infection to latencyJ Virol77200348484857
- Y.ZhangC.JonesIdentification of functional domains within the bICP0 protein encoded by BHV-1J Gen Virol862005879886
- Elechiguerra JL, Burt JL, Morones JR, Camacho-Bragado A. et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 2005;3:6.
- A.M.FayazA.ZhujunM.GirilalL.ChenX.XiaoP.T.KalaichelvanInactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infectionInt J Nanomedicine7201250075018
- K.KawataM.OsawaS.OkabeIn vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cellsEnviron Sci Technol43200960466051
- R.L.HuS.R.LiF.J.KongR.J.HouX.L.GuanF.Guoinhibition effect of silver nanoparticles on herpes simplex virus 2Genet Mol Res13201470227028